PRLD compared with ACET: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

ACETAdicet Bio, Inc.

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

ACETAdicet Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only ACET 4

REGNRegeneronsupplier

TWSTTwist Biosciencesupplier

CRSPCRISPR Therapeuticssupplier

—City of Hopeunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

PRLDPrelude Therapeutics Inc

3.840.00%

Mkt cap$306.4MRevenue$6MQ2 FY26

ACETAdicet Bio, Inc.

3.30▲+2.97%

Regular sessionNov 3 '26

Mkt cap$30.0MRevenue—

Compare

Regular sessionNov 3 '26

PRLDPrelude Therapeutics Inc

ACETAdicet Bio, Inc.

3.840.00%

Price

3.30▲+2.97%

$306.4M

Mkt cap

$30.0M

Q2 FY26$6M

Revenue

—

PRLD3.840.00%vsACET3.30▲+2.97%Regular sessionNov 3 '26